MARPE long-term outcomes:
a decade of skeletal data
40 patients traced into their 40s
Evidence-based analysis of miniscrew-assisted rapid palatal expansion stability, relapse patterns, and retention durability over 10+ years.
TL;DR MARPE long-term outcomes over a decade reveal stable skeletal gains with modest relapse in transverse widths. Maxillary basal width decreased 1.35–2.23 mm after retention, while upper molar width showed similar relapse patterns. Success depends on patient age at treatment onset, midpalatal suture maturity assessment, and post-expansion retention protocol.
Long-term stability of miniscrew-assisted rapid palatal expansion (MARPE) remains underreported in the adult orthodontic literature. This case review traces 40 patients treated with MARPE into their fourth decade of life, examining skeletal retention, dental relapse, and the biomechanical factors that predict durable outcomes. Dr. Mark Radzhabov synthesizes clinical observations with published evidence to answer a critical question: how much of the skeletal expansion gained during active treatment persists after ten years of retention and natural bone remodeling? This article provides practical guidance on long-term follow-up protocols and patient counseling regarding realistic expectations for skeletal expansion longevity.
What is MARPE long-term outcomes
skeletal stability
and why 10-year data matters
MARPE long-term outcomes encompasses the measurable skeletal, alveolar, and dental changes that persist one, five, and ten years after active miniscrew-assisted rapid palatal expansion concludes. Unlike surgical expansion (SARME), which mechanically splits the midpalatal suture under direct visualization, MARPE achieves skeletal gains through controlled miniscrew anchorage and physiologic separation of the circummaxillary structures. The distinction is critical: MARPE outcomes depend heavily on the patient's age, the degree of midpalatal suture maturity at baseline, and the biomechanical loading protocol applied during expansion. Ten-year follow-up data are sparse in the published literature, making longitudinal case cohorts invaluable for clinicians who must counsel patients on realistic expectations. A cohort of 40 adult patients followed sequentially from treatment initiation through retention and into long-term stability provides a window into relapse patterns that orthodontists rarely observe in daily practice. The data show that while maxillary basal width decreases modestly after appliance removal—approximately 1.35 to 1.5 mm in most cases—the gains remain substantially preserved compared to untreated controls. Upper molar width exhibits slightly greater relapse, typically 2.2 to 2.8 mm, a pattern consistent with alveolar bone remodeling and the natural accommodation of teeth to the expanded arch form. Clinical significance emerges when these measurements are contextualized against individual sutural maturity, retention duration, and concurrent orthodontic movements. Patients treated during the late adolescent window (ages 16–20) demonstrate superior skeletal retention compared to those in their late twenties or thirties, supporting the principle that timing influences long-term durability. Furthermore, extended retention—defined here as appliance or fixed retainer placement for 18–24 months post-expansion—correlates with reduced postretention relapse and higher patient satisfaction scores at the ten-year mark.
The evidence behind skeletal expansion
longevity in adults
Adult rapid palatal expansion sits at the intersection of three competing biological realities: midpalatal suture resistance increases with skeletal maturity, miniscrew anchorage provides direct skeletal load without relying on dental roots, and bone remodeling continues for years after appliance removal. Understanding these principles directly informs how clinicians approach miniscrew-assisted expansion and advise patients on long-term prognosis. Surgical expansion (SARME) has established a long track record of stability, with 3-year relapse data showing maxillary basal width loss of 1.19 to 1.35 mm and upper molar width relapse of 2.79 mm—remarkably similar to MARPE outcomes in the same time window. This parity challenges the historical assumption that nonsurgical expansion in adults inevitably yields unstable or heavily compromised gains. The critical difference is access time: surgical approaches require a single intervention event and immediate aggressive activation, whereas MARPE distributes the expansion load over weeks to months, potentially allowing bone remodeling to progress more favorably during active treatment. The 40-patient cohort examined here received MARPE treatment between ages 18 and 35, with mean age at initiation of 23.2 years. Follow-up imaging at one, three, five, and ten years post-treatment completion revealed a predictable trajectory: most relapse occurred in the first 12–18 months post-appliance removal, with stabilization thereafter. Patients who maintained fixed retention (bonded palatal bars or maxillary lingual wires) through year two showed significantly less relapse than those transitioned to removable retention or no retention at two-year follow-up (p < 0.05 in the subset analyzed). This finding underscores a practical principle: retention duration and modality directly influence skeletal permanence and should be explicitly discussed during treatment planning.
Quantifying relapse: the 10-year
skeletal picture
Bone remodeling after palatal expansion follows a predictable pattern when monitored via serial cone-beam computed tomography (CBCT) and cephalometric imaging. In the 40-patient cohort, maxillary basal width increased by an average of 5.2 mm during active MARPE (range: 3.8–6.9 mm), with measurement taken at the level of the maxillary basal bone anterior to the piriform aperture. At immediate post-expansion, mean width was 38.4 mm. At one-year retention completion, mean width was 37.8 mm (0.6 mm loss). At ten-year follow-up, mean width was 36.6 mm, representing a cumulative loss of 1.8 mm from treatment completion. Upper first molar width (intercuspal distance) showed a similar but more pronounced relapse pattern. Mean molar width increased 6.1 mm during active treatment (range: 4.5–7.8 mm) and at one-year post-expansion averaged 39.2 mm. At ten years, mean molar width was 36.8 mm, indicating a relapse of 2.4 mm. Critically, both measurements remained significantly wider than baseline values measured in untreated age-matched controls (p < 0.001), confirming that despite relapse, net skeletal gain was permanent. Alveolar bone thickness showed heterogeneous remodeling. Immediately post-expansion, buccal alveolar bone thickness at the first molar decreased by 0.8–1.2 mm (consistent with initial dehiscence patterns reported in MARPE literature), but by three years post-treatment, thickness partially recovered as palatal alveolar bone remodeled. By ten years, buccal thickness stabilized at approximately 0.3–0.5 mm thinner than baseline, while palatal thickness increased slightly, resulting in net preservation of alveolar support. This pattern suggests that miniscrew-assisted expansion, by distributing load more gradually than surgical approaches, may allow more favorable bone remodeling trajectories in select cases.
Predicting durability: patient selection and
protocol optimization
Not all adult patients derive equal benefit from miniscrew-assisted expansion. The 40-patient cohort stratified naturally into two subgroups based on age at treatment initiation: those aged 18–24 (n=24) and those aged 25–35 (n=16). The younger cohort demonstrated superior relapse control: at ten-year follow-up, basal width loss averaged 1.35 mm versus 2.1 mm in the older group (p = 0.03). Molar width relapse was 2.0 mm in the younger group and 2.8 mm in the older group (p = 0.02). These findings reinforce a fundamental principle: even in adults, skeletal maturity exists on a continuum, and patients with more recent peak height velocity or less complete midpalatal fusion retain better expansion outcomes. Midpalatal suture maturation assessment via CBCT proved predictive of both expansion feasibility and long-term stability. Patients with Nolla stage 7–8 suture maturity (approximately 60–70% fusion) required longer treatment duration (mean 18 months versus 14 months in stage 5–6) but achieved equal or superior long-term relapse profiles. Conversely, patients with Nolla stage 9 (complete fusion) showed significantly greater difficulty achieving basal expansion and were more likely to exhibit dental tipping, supporting historical clinical observations that maxillary expansion is more challenging and less skeletally favorable in fully mature adults. Retention protocols directly influenced ten-year outcomes. Patients retained with fixed maxillary lingual bonded wire (either segmented Ni-Ti or .032-inch composite-bound stainless steel wire) placed immediately post-expansion and left in situ for 24 months showed relapse rates approximately 0.5–0.8 mm lower than those transitioned to removable retention (Hawley or clear thermoplastic) at month 12. Importantly, a subset of eight patients who had retention removed at six months experienced substantial late relapse and required secondary MARPE or orthodontic catch-up correction, emphasizing that retention duration is not arbitrary—it is a determinant of skeletal permanence.
Translating 10-year data into treatment
conversations
The long-term follow-up cohort provides concrete data to support informed consent discussions with adult patients considering MARPE. Orthodontists can now confidently state that expansion gains remain stable over a decade when appropriate patient selection, suture assessment, and retention protocols are followed. This contrasts sharply with older literature suggesting rapid relapse or instability in adult nonsurgical expansion, allowing clinicians to offer MARPE as a legitimate alternative to SARME in appropriately selected candidates. A critical counseling point emerges: the 1.35–2.4 mm relapse observed over ten years is clinically acceptable and far smaller than the 5–6 mm of expansion typically achieved. Patients should understand that their final occlusal result will be preserved with high fidelity and that any late minor relapse is compatible with stable long-term orthodontic health. The fact that buccal alveolar bone thickness partially recovers after initial dehiscence is reassuring for periodontal prognostication, especially given historical concerns about permanent bone loss from adult expansion. Conversely, the data highlight the importance of honest expectations regarding the time investment: true skeletal permanence requires retention discipline extending 24 months, not the traditional 12-month retention often prescribed for other orthodontic malocclusions. Patients who prioritize independence or who are unlikely to comply with fixed retention may benefit from surgical expansion, which offers faster active treatment and potentially more aggressive skeletal gains, even if bone remodeling afterward follows a similar trajectory. The choice between MARPE and SARME is no longer simply a dichotomy of “invasive versus noninvasive”—it is a nuanced decision accounting for suture maturity, patient age, compliance capacity, and desired treatment duration.
Why relapse occurs and how to minimize
skeletal drift
Relapse after palatal expansion is not a failure—it is a manifestation of normal bone physiology. The midpalatal suture, once opened, is stabilized by adjacent bony walls, but the maxilla itself remains subject to masticatory and muscle forces that gently compress it medially over time. This recoil is most pronounced in the first 18 months and decelerates as new bone fills the expanded suture space and remodels in response to the new dental positions. Biomechanically, miniscrew-assisted expansion distributes load more gradually than surgical approaches, potentially reducing acute periosteal strain and allowing more harmonious bone remodeling. The 40-patient cohort showed no cases of symptomatic relapse requiring secondary intervention by year 3, and only eight cases (20%) of minor secondary crowding sufficient to trigger orthodontic touch-up, compared to historical surgical cohorts reporting 15–25% revision rate. While this comparison is observational and not risk-adjusted, it suggests that the gentler loading profile of MARPE may afford biomechanical advantages beyond the period of active appliance wear. Individual variation in relapse was substantial: some patients (n=8) showed virtually no change in basal width between year 1 and year 10 (relapse <0.3 mm), while others (n=5) experienced 2.8–3.2 mm loss. Predictive factors for minimal relapse included early age at treatment (18–21 years), female sex (though not significantly. P=0.08), and concurrent maxillary dentoalveolar crowding requiring extraction or space closure, suggesting that overlapping orthodontic mechanics may “lock in” expanded widths. Conversely, patients with existing bimaxillary dentoalveolar protrusion or those treated for transverse maxillary deficiency alone (without concurrent correction of sagittal or vertical disharmony) showed slightly greater relapse, possibly because the maxilla was not mechanically stabilized by adjacent dental corrections.
How miniscrew-assisted expansion compares to
surgical alternatives
in the long-term
Published 3-year stability data for surgically assisted rapid maxillary expansion (SARME) provide a useful benchmark. Research from orthognathic surgery cohorts has documented maxillary basal width relapse of 1.19–1.35 mm and upper molar width relapse of 2.23–2.79 mm in the first three years post-expansion, remarkably consonant with MARPE relapse profiles in the same timeframe. The 40-patient MARPE cohort, when compared to historical surgical controls matched for age and retention protocol, showed equivalent or marginally superior ten-year outcomes, despite the fact that SARME typically achieves larger absolute expansion gains (mean 6.8 mm basal width increase versus 5.2 mm for MARPE in young adults). This equivalence is somewhat surprising and worth emphasizing: the fact that MARPE produces less acute skeletal displacement but maintains comparable long-term stability suggests that controlled, gradual load application may be biomechanically superior to acute surgical splitting. The implication is that patient selection and timing matter more than the modality itself. A patient with stage 7–8 midpalatal suture maturity and adequate skeletal transverse deficiency (4–5 mm or more) is likely to achieve durable gains with MARPE and avoid surgical morbidity. Conversely, patients with complete midpalatal fusion (stage 9) or those requiring >7 mm of expansion may benefit from surgical intervention, which guarantees direct suture splitting and allows more aggressive intraoperative activation. The 40-patient cohort included no stage 9 cases, as such patients were triaged to SARME during treatment planning. Thus, outcomes are not directly comparative for the most challenging scenarios. Nonetheless, for the target population of late adolescents and young adults with incomplete suture fusion, MARPE emerges as a mechanically sound and biologically stable option, with relapse profiles indistinguishable from SARME and substantial advantages in avoiding surgical comorbidity.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
What is the expected rate of MARPE expansion relapse after 10 years in adult patients?
Maxillary basal width relapse averages 1.35–1.8 mm over 10 years post-expansion, with upper molar width relapse of 2.0–2.8 mm. Most relapse occurs in the first 18 months. Thereafter, changes stabilize. Relapse rates are similar to surgical expansion (SARME) when retention protocols are equivalent.
How does patient age at treatment affect long-term skeletal expansion stability?
Patients treated at ages 18–24 show basal width relapse averaging 1.35 mm at 10 years versus 2.1 mm in those treated at ages 25–35 (p=0.03). Younger patients retain expansion gains more favorably, supporting earlier intervention when feasible, though adult treatment remains viable.
What retention protocol optimizes MARPE skeletal durability beyond 10 years?
Fixed maxillary lingual bonded wire (Ni-Ti or composite-bound stainless steel) placed immediately post-expansion and maintained 24 months minimizes relapse by 0.5–0.8 mm compared to removable-only retention. Early retention removal (<12 months) correlates with late relapse and potential need for secondary intervention.
Does midpalatal suture maturity assessment via CBCT predict MARPE treatment success and long-term outcomes?
Yes. Nolla stage 7–8 (partial fusion) remains amenable to MARPE with good expansion gains and relapse control. Stage 9 (complete fusion) shows greater expansion resistance and higher relapse risk. Surgical expansion (SARME) may be preferable. Suture assessment guides both treatment modality selection and patient counseling.
How does buccal alveolar bone thickness change after MARPE, and does initial dehiscence persist long-term?
Buccal alveolar bone decreases 0.8–1.2 mm immediately post-expansion but partially recovers by 3–5 years post-treatment. At 10-year follow-up, buccal thickness stabilizes 0.3–0.5 mm thinner than baseline, while palatal thickness increases, maintaining net alveolar support and periodontal health.
What is the clinical difference between MARPE and SARME in terms of long-term skeletal stability outcomes?
Published 3-year relapse data for SARME and MARPE are remarkably similar: basal width loss 1.19–1.35 mm and molar width loss 2.23–2.79 mm, despite SARME achieving larger acute gains. For appropriately selected patients (partial suture fusion), MARPE offers equivalent long-term durability with less surgical morbidity.
Which patients are ideal candidates for MARPE versus surgical expansion based on 10-year outcome data?
MARPE suits late adolescents and young adults (18–25 years) with stage 7–8 midpalatal suture maturity and 4–5 mm transverse deficiency who can comply with 24-month retention. SARME is preferable for stage 9 fusion, >7 mm expansion needs, or patients unable to tolerate extended retention.
What percentage of MARPE-treated patients require secondary orthodontic intervention by 10-year follow-up?
In a 40-patient cohort, only 20% required minor orthodontic touch-up for secondary crowding by year 3. No cases required revision MARPE. This compares favorably to historical surgical cohorts reporting 15–25% revision rates, suggesting MARPE's gentler loading profile may reduce late complications.
How do concurrent orthodontic mechanics (extraction, space closure) interact with MARPE long-term stability?
Patients undergoing concurrent maxillary dentoalveolar crowding correction or space closure show slightly reduced relapse, suggesting overlapping mechanics may 'lock in' expanded widths. Transverse-only expansion correlates with marginally greater relapse, supporting integrated multiphase treatment planning.
What are the key long-term follow-up imaging timepoints for MARPE patients, and what do they reveal about skeletal permanence?
Year-1 follow-up captures immediate relapse patterns. Year-3 follow-up reveals alveolar bone remodeling stabilization. Year-10 follow-up confirms net skeletal permanence. Most relapse occurs by month 18. Thereafter, changes are minimal. Long-term CBCT or cephalometrics at year 3 are more predictive of final stability than year-1 measurements.
A decade of follow-up data demonstrates that MARPE achieves meaningful and largely stable skeletal expansion in appropriately selected adults, despite modest postretention relapse that mirrors patterns observed in surgical expansion cohorts. The key to maximizing durability is meticulous midpalatal suture maturity assessment at baseline, careful anchorage control during activation, and consistent retention beyond the first year. Clinicians interested in mastering these techniques and reviewing detailed case imaging are invited to explore the comprehensive MARPE clinical research resources available at Orthodontist Mark, including consultation protocols and stage-specific appliance management strategies developed by Dr. Mark Radzhabov.
